IRDiRC is pleased to share that Shirlene Badger has been elected Vice-Chair of the International Rare Diseases Research Consortium’s Companies Constituent Committee (CCC). Shirlene leads Global Patient Advocacy at Illumina Inc., where she advances patient-centered genomics across rare and undiagnosed genetic disease, reproductive health, newborn screening, infectious disease, and oncology. A medical sociologist trained at […]
Read More
The IRDiRC Companies Constituent Committee (CCC) is pleased to welcome PacBio as its newest member, represented by Nina Gonzaludo, Global Lead Human Genomics, based in the USA. PacBio is a global leader in long-read sequencing technologies, enabling more comprehensive and accurate genomic insights. These advances play a critical role in accelerating progress in rare disease research and improving diagnostic capabilities. […]
Read More